- Home
- HRTX vs ACRE Comparison
HRTX vs ACRE Comparison
Compare HRTX & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- ACRE
- Stock Information
- Founded
- HRTX 1983
- ACRE 2011
- Country
- HRTX United States
- ACRE United States
- Employees
- HRTX N/A
- ACRE N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- ACRE Real Estate Investment Trusts
- Sector
- HRTX Health Care
- ACRE Real Estate
- Exchange
- HRTX Nasdaq
- ACRE Nasdaq
- Market Cap
- HRTX 325.0M
- ACRE 270.6M
- IPO Year
- HRTX 1987
- ACRE 2012
- Fundamental
- Price
- HRTX $2.14
- ACRE $4.83
- Analyst Decision
- HRTX Strong Buy
- ACRE Hold
- Analyst Count
- HRTX 2
- ACRE 7
- Target Price
- HRTX $5.00
- ACRE $5.50
- AVG Volume (30 Days)
- HRTX 1.5M
- ACRE 483.5K
- Earning Date
- HRTX 08-05-2025
- ACRE 08-05-2025
- Dividend Yield
- HRTX N/A
- ACRE 12.45%
- EPS Growth
- HRTX N/A
- ACRE N/A
- EPS
- HRTX N/A
- ACRE N/A
- Revenue
- HRTX $148,518,000.00
- ACRE $67,129,000.00
- Revenue This Year
- HRTX $12.08
- ACRE N/A
- Revenue Next Year
- HRTX $12.57
- ACRE N/A
- P/E Ratio
- HRTX N/A
- ACRE N/A
- Revenue Growth
- HRTX 12.43
- ACRE 83.51
- 52 Week Low
- HRTX $1.04
- ACRE $3.35
- 52 Week High
- HRTX $3.73
- ACRE $7.99
- Technical
- Relative Strength Index (RSI)
- HRTX 52.11
- ACRE 46.95
- Support Level
- HRTX $1.90
- ACRE $4.74
- Resistance Level
- HRTX $2.22
- ACRE $5.04
- Average True Range (ATR)
- HRTX 0.11
- ACRE 0.13
- MACD
- HRTX 0.01
- ACRE -0.03
- Stochastic Oscillator
- HRTX 54.55
- ACRE 9.68
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.